December 5, 2013
bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, has announced that it is moving a new step forward to its comprehensive automation solution dedicated for reference or centralized molecular biology laboratories. As a key component of this modular automation solution, bioMérieux has selected Life Technologies’ 7500 instrument range as its preferred [...]
Media Cybernetics® Releases the All New Image-Pro® Premier 9.1 Image Analysis Software
December 5, 2013
Rockville, MD -- New life science features include colocalization of multiple fluorescent images or channels; learning classification of tissues or cells using multiple parameters for Pathologists; automated wound healing analysis; and advanced ring analysis for otoliths, scales and trees. New industrial inspection and material analysis features include layer thickness measurements; wire bonding corrosion analysis; bubble, [...]
Cellectis announces an acceleration of its strategic refocusing on therapeutics and agrobusiness
December 5, 2013
Paris, France – Cellectis SA (Alternext: ALCLS) is looking to accelerate its strategic refocusing on therapeutics and agrobusiness through a large scale reorganization. Since 2010, a sudden and spectacular paradigm shift has been radically changing business models across the entire biotech industry. Since the beginning of the year, sales of genome engineering tools for research, [...]
MO BIO Laboratories, Inc. becomes ISO 9001:2008 certified
December 5, 2013
CARLSBAD, Calif. -- MO BIO Laboratories, Inc., the leader in soil, microbial, stool, and plant nucleic acid purification, has been independently audited and is now ISO 9001:2008 certified for the design and manufacture of reagents and kits for extraction, purification and analysis of samples for the life science research community, along with providing 3rd party [...]
Promega Introduces QuantiFluor ONE dsDNA System for Sensitive “Add-and-Read” DNA Quantitation
December 5, 2013
Madison, WI USA. - Promega Corporation announced today the launch of the QuantiFluor® ONE dsDNA System, a sensitive, dsDNA-specific fluorescent dye suitable for use in both research and clinical workflows. The new dye system is integrated into the new Promega Quantus™ Fluorometer and GloMax® detection instruments, but is compatible with any fluorometer capable of measuring [...]
Datacolor Continues International Growth by Founding a New Sales and Service Company in Brazil
December 4, 2013
Lawrenceville, NJ – Datacolor® (www.datacolor.com), a global leader in color management solutions, today announced the opening of its newest legal entity in São Paulo, Brazil. With the creation of its São Paulo based company, Datacolor is better equipped to participate in the country’s growing market for color management solutions in industries such as textile and [...]
December 4, 2013
Strand Life Sciences Private Limited, a global life sciences company headquartered in Bangalore, is collaborating with the San Francisco Bay Area based El Camino Hospital to locate a Strand Center for Genomics and Personalized Medicine at the Genomic Medicine Institute of the El Camino Hospital to accelerate the adoption of next generation sequencing based research [...]
December 4, 2013
Cambridge, UK: TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications, is pleased to announce its Fill-It™, automated benchtop vial filling system is being routinely used at an innovative cell therapy company developing novel cancer immunotherapies, to improve processing speed and throughput of large batches of cells in [...]
Roche receives FDA clearance to use additional specimen types for chlamydia and gonorrhea test
December 4, 2013
PLEASANTON, Calif. -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of four additional specimen types with the cobas® CT/NG v2.0 Test to help physicians diagnose Chlamydia trachomatis (CT) and Neisseria Gonorrhoeae (NG) infections in symptomatic and asymptomatic [...]
December 4, 2013
OAKLAND, Calif. & SALT LAKE CITY -- Omicia, Inc., has announced a partnership with the University of Utah’s Utah Genome Project. Under a two-year licensing agreement with Omicia, the University will use and advance Opal, the company’s whole genome analysis platform for research and clinical applications. The agreement enables the University’s researchers and clinicians to [...]

